DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Dermata Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.86−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- $3.46M
- P/E (TTM)
- –
- Dividend yield
- –
Dermata Therapeutics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Dermata Therapeutics | Industry median |
|---|---|---|
| Market Cap | $3.46M | $197.05M |
| Enterprise Value | -$954.12K | $106.56M |
| PB Ratio | 0.99 | 2.14 |
| P/TBV Ratio | 0.99 | 2.46 |
Income (trailing twelve months)
| Measure | Dermata Therapeutics | Industry median |
|---|---|---|
| Operating Income | -$8.60M | -$21.44M |
| Net Income | -$8.37M | -$22.46M |
| EBITDA | -$8.60M | -$16.91M |
| EPS (Diluted) | -$4.52 | -$0.83 |
Returns
| Measure | Dermata Therapeutics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -183.9% | -53.1% |
| Return on Assets (ROA) | -139.9% | -41.0% |
Balance sheet
| Measure | Dermata Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.41M | $62.42M |
| Net Cash (Debt) | $4.41M | $15.68M |
| Net Cash Per Share | $1.10 | $0.65 |
| Equity (Book Value) | $3.49M | $48.79M |
| Book Value Per Share | $0.87 | $1.36 |
| Tangible Book Value | $3.49M | $23.06M |
Cash flow (trailing twelve months)
| Measure | Dermata Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -$8.08M | -$12.35M |
Efficiency
| Measure | Dermata Therapeutics | Industry median |
|---|---|---|
| Profits Per Employee | -$929.85K | -$732.08K |
| Employee Count | 9 | 73 |
Dividends and yields
| Measure | Dermata Therapeutics | Industry median |
|---|---|---|
| Earnings Yield | -242.0% | -21.2% |
Shares
| Measure | Dermata Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 4,022,140 | 59,128,900 |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 2,666,210 | 48,744,500 |
| Shares Held by Insiders | 33.7% | 11.8% |
| Shares Held by Institutions | 3.05% | 59.4% |
Scores
| Measure | Dermata Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | -24.74 | 0.10 |
Calculated by StockData from Dermata Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.